Dupont Capital Management Corp Biomarin Pharmaceutical Inc Transaction History

Dupont Capital Management Corp

$1.14 Billion
Q2 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 26, 2023	SELL	$80.93 - $108.63 $214,383 - $287,760	-2,649 Reduced 83.67%	517 $0
Q3 2022 Oct 31, 2022	BUY	$82.16 - $96.94 $109,519 - $129,221	1,333 Added 72.72%	3,166 $268,000
Q2 2022 Jul 26, 2022	BUY	$71.48 - $86.85 $36,240 - $44,032	507 Added 38.24%	1,833 $152,000
Q1 2022 Apr 27, 2022	BUY	$74.28 - $92.69 $3,119 - $3,892	42 Added 3.27%	1,326 $102,000
Q4 2021 Jan 31, 2022	BUY	$71.72 - $91.47 $92,088 - $117,447	1,284 New	1,284 $113,000
Q3 2021 Nov 03, 2021	SELL	$74.77 - $85.47 $163,746 - $187,179	-2,190 Closed	0 $0
Q1 2021 Apr 29, 2021	BUY	$74.73 - $90.69 $22,942 - $27,841	307 Added 16.3%	2,190 $165,000
Q4 2020 Jan 28, 2021	SELL	$72.61 - $90.2 $42,549 - $52,857	-586 Reduced 23.73%	1,883 $165,000
Q3 2020 Oct 29, 2020	SELL	$71.87 - $131.03 $601,551 - $1.1 Million	-8,370 Reduced 77.22%	2,469 $188,000
Q2 2020 Jul 24, 2020	SELL	$79.55 - $124.22 $48,843 - $76,271	-614 Reduced 5.36%	10,839 $1.34 Million
Q1 2020 Apr 29, 2020	BUY	$71.37 - $96.85 $311,958 - $423,331	4,371 Added 61.72%	11,453 $968,000
Q4 2019 Jan 27, 2020	BUY	$64.27 - $86.37 $137,216 - $184,399	2,135 Added 43.16%	7,082 $599,000
Q3 2019 Oct 28, 2019	SELL	$67.4 - $85.11 $79,195 - $100,004	-1,175 Reduced 19.19%	4,947 $333,000
Q2 2019 Jul 30, 2019	SELL	$80.35 - $93.9 $198,384 - $231,839	-2,469 Reduced 28.74%	6,122 $524,000
Q4 2018 Feb 01, 2019	BUY	$80.14 - $106.07 $283,855 - $375,699	3,542 Added 70.15%	8,591 $732,000
Q3 2018 Nov 05, 2018	BUY	$93.92 - $105.72 $474,202 - $533,780	5,049 New	5,049 $490,000
Q2 2018 Jul 30, 2018	SELL	$76.01 - $99.03 $130,509 - $170,034	-1,717 Closed	0 $0
Q1 2018 May 02, 2018	SELL	$77.67 - $92.63 $11,339 - $13,523	-146 Reduced 7.84%	1,717 $139,000
Q4 2017 Jan 31, 2018	SELL	$80.76 - $95.13 $314,964 - $371,007	-3,900 Reduced 67.67%	1,863 $166,000
Q3 2017 Oct 31, 2017	BUY	$80.6 - $94.95 $464,497 - $547,196	5,763	5,763 $536,000

Others Institutions Holding BMRN

# of Institutions

632

Shares Held

185M

Call Options Held

1.63M

Put Options Held

1.2M

Black Rock Inc. New York, NY

22.7M
Shares

$1.6 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

19M
Shares

$1.34 Billion
0.03% of portfolio
Primecap Management CO Pasadena, CA

18.8M
Shares

$1.33 Billion
1.14% of portfolio
Dodge & Cox San Francisco, CA

13.9M
Shares

$983 Million
0.72% of portfolio
Capital Research Global Investors Los Angeles, CA

9.69M
Shares

$684 Million
0.18% of portfolio

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Dupont Capital Management Corp with notifications on news.

Account